- Home
- SANA vs IART Comparison
SANA vs IART Comparison
Compare SANA & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SANA | IART |
|---|---|---|
| Founded | 2018 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | SANA | IART |
|---|---|---|
| Price | $4.45 | $13.65 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 7 |
| Target Price | $7.83 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 4.0M | 774.3K |
| Earning Date | 11-06-2025 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,642,966,000.00 |
| Revenue This Year | N/A | $3.26 |
| Revenue Next Year | N/A | $2.71 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 4.99 |
| 52 Week Low | $1.26 | $10.87 |
| 52 Week High | $7.30 | $27.13 |
Technical Indicators
Market Signals| Indicator | SANA | IART |
|---|---|---|
| Relative Strength Index (RSI) | 50.57 | 53.43 |
| Support Level | $4.01 | $11.86 |
| Resistance Level | $4.91 | $14.12 |
| Average True Range (ATR) | 0.27 | 0.54 |
| MACD | -0.00 | 0.09 |
| Stochastic Oscillator | 52.04 | 59.71 |
Price Performance
Historical ComparisonAbout SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.
About IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.